PAX5A and PAX5B isoforms are both efficient to drive B cell differentiation
Metrics: PDF 1009 views | HTML 1209 views | ?
Charlotte Cresson1,*, Sophie Péron2,*, Laura Jamrog1,*, Nelly Rouquié1, Nais Prade3, Marine Dubois1, Sylvie Hébrard1, Stéphanie Lagarde3, Bastien Gerby1, Stéphane J.C. Mancini4, Michel Cogné5, Eric Delabesse3, Laurent Delpy2 and Cyril Broccardo1
1Inserm, UMR1037 CRCT, F-31000, Université Toulouse III-Paul Sabatier, UMR1037 CRCT, Oncopole, F-31000 Toulouse, France
2Université de Limoges-CNRS UMR 7276, F-87025 Limoges, France
3Inserm, UMR1037 CRCT, F-31000, Université Toulouse III-Paul Sabatier, UMR1037 CRCT, Toulouse Hospital University, Oncopole, CS 53717, F-31000 Toulouse, France
4Aix Marseille Univ, CNRS, INSERM, Institut Paoli-Calmettes, CRCM, F-13009 Marseille, France
5Université de Limoges-CNRS UMR 7276, Institut Universitaire de France, F-87025 Limoges, France
*These authors contributed equally to this work
Cyril Broccardo, email: email@example.com
Keywords: Pax5; transcription factor; B cell development; B cells; acute lymphoblastic leukemia
Received: August 11, 2016 Accepted: July 31, 2018 Published: August 28, 2018
Pax5 is the guardian of the B cell identity since it primes or enhances the expression of B cell specific genes and concomitantly represses the expression of B cell inappropriate genes. The tight regulation of Pax5 is therefore required for an efficient B cell differentiation. A defect in its dosage can translate into immunodeficiency or malignant disorders such as leukemia or lymphoma.
Pax5 is expressed from two different promoters encoding two isoforms that only differ in the sequence of their first alternative exon. Very little is known regarding the role of the two isoforms during B cell differentiation and the regulation of their expression. Our work aims to characterize the mechanisms of regulation of the expression balance of these two isoforms and their implication in the B cell differentiation process using murine ex vivo analyses. We show that these two isoforms are differentially regulated but have equivalent function during early B cell differentiation and may have functional differences after B cell activation. The tight control of their expression may thus reflect a way to finely tune Pax5 dosage during B cell differentiation process.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.